Further analysis of behavioral and endocrine consequences of chronic exposure of male Wistar rats to subtoxic doses of endocrine disruptor chlorobenzenes

Physiology and Behavior

Volumn 103, Issue 5, 2011, Pages 421-430

  Valkusz, Z ^a   Nagyeri G ^a   Radacs M ^b   Ocsko T ^b   Hausinger, P ^c   Laszlo M ^b   Laszlo F A ^c   Juhasz A ^a   Julesz, J ^a   Palfoldi R ^a   Galfi M ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Aggression; Anxiety; Chlorobenzenes; Monoamines; Oxytocin; Vasopressin

Indexed keywords

ARGIPRESSIN; CHLOROBENZENE; CORTICOTROPIN; NEUROPEPTIDE; NORADRENALIN; OXYTOCIN; SEROTONIN;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOCRINE FUNCTION; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HYPOPHYSIS; IMMUNOCHEMILUMINESCENCE; LONG TERM EXPOSURE; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STOMACH TUBE; STRESS;

ADRENOCORTICOTROPIC HORMONE; AGGRESSION; ANIMALS; ANXIETY; ARGININE VASOPRESSIN; CELLS, CULTURED; CHLOROBENZENES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENVIRONMENTAL POLLUTANTS; HEXACHLOROBENZENE; MALE; MAZE LEARNING; MOTOR ACTIVITY; NOREPINEPHRINE; OXYTOCIN; PITUITARY GLAND, POSTERIOR; RATS; RATS, WISTAR; SEROTONIN;

EID: 79955105702     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.03.016     Document Type: Article

References (67)

1. Breivik K., Alcock R., Li Y.F., Bailey R.E., Fiedler H., Pacyna J.M. Primary sources of selected POPs: regional and global scale emission inventories. Environ Pollut 2004, 128:3-16.
2. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993, 101:378-384.
3. Zala S.M., Penn D.J. Abnormal behaviours induced by chemical pollution: a review of the evidence and new challenges. Anim Behav 2004, 68:649-664.
4. Vos J.G., Dybing E., Greim H.A., Ladefoged O., Lambre C., Tarazona J.V., et al. Health effects of endocrine-disrupting chemicals on wildlife, with special reference to the European situation. Crit Rev Toxicol 2000, 30:71-133.
5. Ugrumov M.V. Developing brain as an endocrine organ: a paradoxical reality. Neurochem Res 2010, 35(6):837-850.
6. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 2004, 25:150-176.
7. Engelmann M., Landgraf R., Wotjak C.T. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol 2004, 25:132-149.
8. Neumann I.D., Veenema A.H., Beiderbeck D.I. Aggression and anxiety: social context and neurobiological links. Front Behav Neurosci 2010, 4:12.
9. Frank E., Landgraf R. The vasopressin system-from antidiuresis to psychopathology. Eur J Pharmacol 2008, 583:226-242.
10. Blanchard R.J., Wall P.M., Blanchard D.C. Problems in the study of rodent aggression. Horm Behav 2003, 44:161-170.
11. Caldwell H.K., Lee H.J., Macbeth A.H., Young W.S. Vasopressin: behavioral roles of an "original" neuropeptide. Prog Neurobiol 2008, 84:1-24.
12. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., et al. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr Rev 2009, 30:293-342.
13. McKinlay R., Plant J.A., Bell J.N., Voulvoulis N. Endocrine disrupting pesticides: implications for risk assessment. Environ Int 2008, 34:168-183.
14. Barber J.L., Sweetman A.J., van Wijk D., Jones K.C. Hexachlorobenzene in the global environment: emissions, levels, distribution, trends and processes. Sci Total Environ 2005, 349:1-44.
15. Bailey R.E. Global hexachlorobenzene emissions. Chemosphere 2001, 43:167-182.
16. California Public Health Goal 1,2,4-trichlorobenzene in drinking water. Office of Environmental Health Hazard Assessment California Environmental Protection Agency 1999.
17. IPCS Chlorobenzenes other than hexachlorobenzene: environmental aspect. Concise International Chemical Assessment Document 60. Geneva: World Health Organization, International Programme on Chemical Safety 2004.
18. ATSDR Toxicological profile for hexachlorobenzene. Atlanta: Agency for Toxic Substances and Disease Registry 2002.
19. Ingebrigtsen K., Nafstad I. Distribution and elimination of C-14-Labeled hexachlorobenzene after single oral-exposure in the male-rat. Acta Pharmacol Toxicol 1983, 52:254-260.
20. den Besten C., Vet J.J., Besselink H.T., Kiel G.S., van Berkel B.J., Beems R., et al. The liver, kidney, and thyroid toxicity of chlorinated benzenes. Toxicol Appl Pharmacol 1991, 111:69-81.
21. Evangelista deDuffard A.M., Duffard R. Behavioral toxicology, risk assessment, and chlorinated hydrocarbons. Environ Health Perspect 1996, 104:353-360.
22. Peters H.A., Cripps D.J., Gocmen A., Erturk E., Bryan G.T., Morris C.R. Neurotoxicity of hexachlorobenzene-induced porphyria turcica. IARC Sci. Publ 1986, 575-579.
23. Bleavins M.R., Bursian S.J., Brewster J.S., Aulerich R.J. Effects of dietary hexachlorobenzene exposure on regional brain biogenic amine concentrations in mink and European ferrets. J Toxicol Environ Health 1984, 14:363-377.
24. Janaky T., Szabo P., Kele Z., Balaspiri L., Varga C., Galfi M., et al. Identification of oxytocin and vasopressin from neurohypophyseal cell culture. Rapid Commun Mass Spectrom 1998, 12:1765-1768.
25. Klivenyi P., Bende Z., Hartai Z., Penke Z., Nemeth H., Toldi J., et al. Behaviour changes in a transgenic model of Huntington's disease. Behav Brain Res 2006, 169:137-141.
26. Biro E., Penke B., Telegdy G. Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats. Neuropeptides 1997, 31:281-285.
27. Mikics E., Kruk M.R., Haller J. Genomic and non-genomic effects of glucocorticoids on aggressive behavior in male rats. Psychoneuroendocrinology 2004, 29:618-635.
28. Galfi M., Janaky T., Toth R., Prohaszka G., Juhasz A., Varga C., et al. Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures. Regul Pept 2001, 98:49-54.
29. Kennedy P.G., Lisak R.P., Raff M.C. Cell type-specific markers for human glial and neuronal cells in culture. Lab Investig 1980, 43:342-351.
30. Michlerstuke A., Bottenstein J.E. Proliferation of glial-derived cells in defined media. J Neurosci Res 1982, 7:215-228.
31. Galfi M., Radacs M., Juhasz A., Laszlo F., Molnar A., Laszlo F.A. Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture. Regul Pept 2005, 127:225-231.
32. Radacs M., Galfi M., Nagyeri G., Molnar A.H., Varga C., Laszlo F., et al. Significance of the adrenergic system in the regulation of vasopressin secretion in rat neurohypophyseal tissue cultures. Regul Pept 2008, 148:1-5.
33. Radacs M., Molnar A.H., Laszlo F.A., Varga C., Laszlo F., Galfi M. Inhibitory effect of galanin on adrenaline- and noradrenaline-induced increased oxytocin secretion in rat neurohypophyseal cell cultures. J Mol Neurosci 2010, 42(1):59-66.
34. Adjarov D., Ivanov E., Keremidchiev D. Gamma-glutamyl transferase: a sensitive marker in experimental hexachlorobenzene intoxication. Toxicology 1982, 23:73-77.
35. Nagyeri G., Galfi M., Radacs M., Molnar A.H., Laszlo F., Varga C., et al. Effects of galanin-monoaminergic interactions on vasopressin secretion in rat neurohypophyseal cell cultures. Regul Pept 2009, 155:76-80.
36. Lilienthal H., Benthe C., Heinzow B., Winneke G. Impairment of schedule-controlled behavior by pre- and postnatal exposure to hexachlorobenzene in rats. Arch Toxicol 1996, 70:174-181.
37. Uhnak J., Veningerova M., Madaric A., Szokolay A. Dynamics of hexachlorobenzene residues in the food chain. IARC Sci. Publ 1986, 109-113.
38. Willes R.F., Nestmann E.R., Miller P.A., Orr J.C., Munro I.C. Scientific principles for evaluating the potential for adverse effects from chlorinated organic chemicals in the environment. Regul Toxicol Pharmacol 1993, 18:313-356.
39. Sawchenko P.E., Swanson L.W., Steinbusch H.W., Verhofstad A.A. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res 1983, 277:355-360.
40. Vacher C.M., Fretier P., Creminon C., Calas A., Hardin-Pouzet H. Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. J Neurosci 2002, 22:1513-1522.
41. Leibowitz S.F., Eidelman D., Suh J.S., Diaz S., Sladek C.D. Mapping study of noradrenergic stimulation of vasopressin release. Exp Neurol 1990, 110:298-305.
42. Veenema A.H., Blume A., Niederle D., Buwalda B., Neumann I.D. Effects of early life stress on adult male aggression and hypothalamic vasopressin and serotonin. Eur J Neurosci 2006, 24:1711-1720.
43. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000, 12(Suppl 1):2-19.
44. Jorgensen H., Kjaer A., Knigge U., Moller M., Warberg J. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. J Neuroendocrinol 2003, 15:564-571.
45. Jorgensen H.S. Studies on the neuroendocrine role of serotonin. Dan Med Bull 2007, 54:266-288.
46. Jorgensen H., Knigge U., Kjaer A., Warberg J. Serotonergic involvement in stress-induced vasopressin and oxytocin secretion. Eur J Endocrinol 2002, 147:815-824.
47. Knigge U., Willems E., Kjaer A., Jorgensen H., Warberg J. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion. Endocrinology 1999, 140:3713-3719.
48. Kimura T., Share L., Wang B.C., Crofton J.T. The role of central adrenoreceptors in the control of vasopressin release and blood pressure. Endocrinology 1981, 108:1829-1836.
49. Kimura T., Shoji M., Iitake K., Ota K., Matsui K., Yoshinaga K. The role of central alpha 1- and alpha 2-adrenoceptors in the regulation of vasopressin release and the cardiovascular system. Endocrinology 1984, 114:1426-1432.
50. Leng G., Brown C.H., Russell J.A. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 1999, 57:625-655.
51. Michaloudi H.C., el Majdoubi M., Poulain D.A., Papadopoulos G.C., Theodosis D.T. The noradrenergic innervation of identified hypothalamic magnocellular somata and its contribution to lactation-induced synaptic plasticity. J Neuroendocrinol 1997, 9:17-23.
52. Bealer S.L., Crowley W.R. Noradrenergic control of central oxytocin release during lactation in rats. Am J Physiol 1998, 274:E453-E458.
53. Boersma C.J., Van Leeuwen F.W. Neuron-glia interactions in the release of oxytocin and vasopressin from the rat neural lobe: the role of opioids, other neuropeptides and their receptors. Neuroscience 1994, 62:1003-1020.
54. Hatton G.I., Perlmutter L.S., Salm A.K., Tweedle C.D. Dynamic neuronal-glial interactions in hypothalamus and pituitary: implications for control of hormone synthesis and release. Peptides 1984, 5(Suppl 1):121-138.
55. Murphy D., Levy A., Lightman S., Carter D. Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt loading. Proc Natl Acad Sci USA 1989, 86:9002-9005.
56. Tweedle C.D., Hatton G.I. Morphological adaptability at neurosecretory axonal endings on the neurovascular contact zone of the rat neurohypophysis. Neuroscience 1987, 20:241-246.
57. Lehmann E., Hanze J., Pauschinger M., Ganten D., Lang R.E. Vasopressin mRNA in the neurolobe of the rat pituitary. Neurosci Lett 1990, 111:170-175.
58. Sladek C.D., Kapoor J.R. Neurotransmitter/neuropeptide interactions in the regulation of neurohypophyseal hormone release. Exp Neurol 2001, 171:200-209.
59. Janosek J., Hilscherova K., Blaha L., Holoubek I. Environmental xenobiotics and nuclear receptors-interactions, effects and in vitro assessment. Toxicol In Vitro 2006, 20:18-37.
60. Hadjab S., Maurel D., Cazals Y., Siaud P. Hexachlorobenzene, a dioxin-like compound, disrupts auditory function in rat. Hear Res 2004, 191:125-134.
61. Cochon A.C., San Martin de Viale L.C., Billi de Catabbi S.C. Phospholipid alterations elicited by hexachlorobenzene in rat brain are strain-dependent and porphyria-independent. Comp Biochem Physiol C Toxicol Pharmacol 2001, 130:199-207.
62. Egashira N., Mishima K., Iwasaki K., Oishi R., Fujiwara M. New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions. J Pharmacol Sci 2009, 109:44-49.
63. de Kloet C.S., Vermetten E., Geuze E., Wiegant V.M., Westenberg H.G. Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder. J Psychiatr Res 2008, 42:192-198.
64. Altemus M., Cizza G., Gold P.W. Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro. Brain Res 1992, 593:311-313.
65. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Marechal P., Pequeux C., et al. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 2007, 32:407-410.
66. Nishioka T., Anselmo-Franci J.A., Li P., Callahan M.F., Morris M. Stress increases oxytocin release within the hypothalamic paraventricular nucleus. Brain Res 1998, 781:56-60.
67. Ryan B.C., Vandenbergh J.G. Developmental exposure to environmental estrogens alters anxiety and spatial memory in female mice. Horm Behav 2006, 50:85-93.